FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3025913312> ?p ?o ?g. }

• W3025913312 endingPage "102766" @default.
• W3025913312 startingPage "102766" @default.
• W3025913312 abstract "ABSTRACT Background Recent advances in the safety, tolerability, and efficacy of hepatitis C virus (HCV) treatments have led to the introduction of policy changes that include, in some settings, universal coverage of direct-acting antiviral (DAA) treatment for people living with HCV. However, people who inject drugs (PWID), a population with disproportionately high rates of HCV, often experience significant social and structural barriers to care, including when seeking treatment and care for blood-borne viruses. The objective of this study is to identify implementation challenges and opportunities for improving HCV-related care and scaling up DAA treatment for PWID living with HCV in a setting with universal DAA coverage since 2018. Methods Informed by a critical interpretive framework, this study thematically analyzes data from in-depth, semi-structured interviews conducted between October 2018 and February 2019 with a purposive sample of 15 expert stakeholders (e.g., clinicians, community-based organization representatives, policy makers) related to HCV care or research in British Columbia, Canada. Results Our analysis revealed two key thematics: First, participants described existing challenges for scaling up DAA treatment, including how contextual factors (e.g., housing, stigma) restrict opportunities for PWID to engage in care. Participants also described how strained and compartmentalized health services are onerous to navigate for patients. Second, participants described opportunities for improving HCV-related care through various structural interventions (e.g., improved housing, decriminalization of substance use), and enhanced and more accessible models of care (e.g., decentralized, integrated, outreach-focused, and peer- and nurse-led services). Conclusions These findings emphasize that several key service delivery and system-level adaptations are required in order to equitably scale up access of DAAs to PWID living with HCV, including policies and programs that are responsive to socio-structural determinants of health." @default.
• W3025913312 created "2020-05-21" @default.
• W3025913312 creator A5005679133 @default.
• W3025913312 creator A5042673268 @default.
• W3025913312 creator A5043289298 @default.
• W3025913312 creator A5070407293 @default.
• W3025913312 creator A5085208411 @default.
• W3025913312 date "2020-07-01" @default.
• W3025913312 modified "2023-09-25" @default.
• W3025913312 title "“Everybody living with a chronic disease is entitled to be cured”: Challenges and opportunities in scaling up access to direct-acting antiviral hepatitis C virus treatment among people who inject drugs" @default.
• W3025913312 cites W1758765645 @default.
• W3025913312 cites W2085028749 @default.
• W3025913312 cites W2087956333 @default.
• W3025913312 cites W2136911795 @default.
• W3025913312 cites W2142011497 @default.
• W3025913312 cites W2148066189 @default.
• W3025913312 cites W2254786358 @default.
• W3025913312 cites W2301185065 @default.
• W3025913312 cites W2313963243 @default.
• W3025913312 cites W2344930730 @default.
• W3025913312 cites W2406118020 @default.
• W3025913312 cites W2554812756 @default.
• W3025913312 cites W2581550425 @default.
• W3025913312 cites W2590576529 @default.
• W3025913312 cites W2597420014 @default.
• W3025913312 cites W2605861831 @default.
• W3025913312 cites W2607660655 @default.
• W3025913312 cites W2609613892 @default.
• W3025913312 cites W2620881498 @default.
• W3025913312 cites W2620977784 @default.
• W3025913312 cites W2626278497 @default.
• W3025913312 cites W2733741613 @default.
• W3025913312 cites W2735091675 @default.
• W3025913312 cites W2743977148 @default.
• W3025913312 cites W2751350641 @default.
• W3025913312 cites W2753756934 @default.
• W3025913312 cites W2762048449 @default.
• W3025913312 cites W2765213034 @default.
• W3025913312 cites W2770394506 @default.
• W3025913312 cites W2790482830 @default.
• W3025913312 cites W2792962057 @default.
• W3025913312 cites W2793631939 @default.
• W3025913312 cites W2794733685 @default.
• W3025913312 cites W2799515680 @default.
• W3025913312 cites W2803289555 @default.
• W3025913312 cites W2808173356 @default.
• W3025913312 cites W2884128589 @default.
• W3025913312 cites W2884142830 @default.
• W3025913312 cites W2884908542 @default.
• W3025913312 cites W2885059679 @default.
• W3025913312 cites W2885311733 @default.
• W3025913312 cites W2888122510 @default.
• W3025913312 cites W2889281626 @default.
• W3025913312 cites W2896689809 @default.
• W3025913312 cites W2903249677 @default.
• W3025913312 cites W2904862898 @default.
• W3025913312 cites W2910201730 @default.
• W3025913312 cites W2912830275 @default.
• W3025913312 cites W2912954134 @default.
• W3025913312 cites W2943994554 @default.
• W3025913312 cites W2969517159 @default.
• W3025913312 cites W2970704508 @default.
• W3025913312 cites W2972879908 @default.
• W3025913312 cites W2987157692 @default.
• W3025913312 doi "https://doi.org/10.1016/j.drugpo.2020.102766" @default.
• W3025913312 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32416525" @default.
• W3025913312 hasPublicationYear "2020" @default.
• W3025913312 type Work @default.
• W3025913312 sameAs 3025913312 @default.
• W3025913312 citedByCount "20" @default.
• W3025913312 countsByYear W30259133122020 @default.
• W3025913312 countsByYear W30259133122021 @default.
• W3025913312 countsByYear W30259133122022 @default.
• W3025913312 countsByYear W30259133122023 @default.
• W3025913312 crossrefType "journal-article" @default.
• W3025913312 hasAuthorship W3025913312A5005679133 @default.
• W3025913312 hasAuthorship W3025913312A5042673268 @default.
• W3025913312 hasAuthorship W3025913312A5043289298 @default.
• W3025913312 hasAuthorship W3025913312A5070407293 @default.
• W3025913312 hasAuthorship W3025913312A5085208411 @default.
• W3025913312 hasConcept C126322002 @default.
• W3025913312 hasConcept C159047783 @default.
• W3025913312 hasConcept C2522874641 @default.
• W3025913312 hasConcept C2779134260 @default.
• W3025913312 hasConcept C3020491458 @default.
• W3025913312 hasConcept C71924100 @default.
• W3025913312 hasConceptScore W3025913312C126322002 @default.
• W3025913312 hasConceptScore W3025913312C159047783 @default.
• W3025913312 hasConceptScore W3025913312C2522874641 @default.
• W3025913312 hasConceptScore W3025913312C2779134260 @default.
• W3025913312 hasConceptScore W3025913312C3020491458 @default.
• W3025913312 hasConceptScore W3025913312C71924100 @default.
• W3025913312 hasLocation W30259133121 @default.
• W3025913312 hasOpenAccess W3025913312 @default.
• W3025913312 hasPrimaryLocation W30259133121 @default.
• W3025913312 hasRelatedWork W2016551366 @default.
• W3025913312 hasRelatedWork W2121676840 @default.
• W3025913312 hasRelatedWork W2123163123 @default.

• next